James V Cassella insider trades

Open-market stock purchases and sales by James V Cassella, Chief Development Officer at Trevi Therapeutics, Inc, from SEC Form 4 filings since Jan 19, 2011.

Recent trades

DateStockTradeValue
Feb 19, 2026TRVI Trevi Therapeutics, IncBought (not open market)—

Companies traded

  • TRVI Trevi Therapeutics, Inc: other filings, last Feb 19, 2026
  • CNCE Concert Pharmaceuticals, Inc: 9 sales, last Mar 6, 2023
  • ALXA Alexza Pharmaceuticals Inc: 3 sales, last Jul 7, 2014

Get free alerts when James V Cassella files a new trade →